— Know what they know.
Not Investment Advice
Also trades as: GMAB (NASDAQ) · $vol 127M · GMAB.CO (CPH) · $vol 55M · GE9.F (FSX) · $vol 0M

GNMSF Earnings

Genmab A/S
1W: +13.0% 1M: +23.7% 3M: +51.8% YTD: +39.8% 1Y: +47.7% 3Y: +46.5% 5Y: -2.2%
$439.05
-8.50 (-1.90%)
After Hours: $441.73 (+2.68, +0.61%)
Weekly Expected Move ±10.1%
$357 $402 $448 $493 $538
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 76 · $27.0B mcap · 56M float · 0.0022% daily turnover · Short 43% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $6.49 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.48B.
Distance to default 7.47 (Merton model): prices to 2026-10-23, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Last Earnings 2026-08-06
EPS
kr 4.91 (US$0.73)
▲ Beat +37.9%
Revenue
kr 1.2B ($172M)
▲ Beat +3.5%
Next Earnings 2026-11-05
EPS Estimate
kr 2.95 (US$0.44)
Range: kr 2.73 - kr 3.58
Revenue Estimate
kr 1.3B ($189M)
1 analysts
1 USD = 6.72 DKK

Estimate vs Actual

Earnings Surprise History

14/19
EPS Beats
14/19
Revenue Beats
74%
EPS Beat Rate
74%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-26 annual 2027-12-31 kr 17.30 kr 17.37 ▲ 0.07 kr 5,345,530,402 kr 5,349,180,765
2026-10-26 quarter 2026-12-30 kr 2.95 kr 2.95 — kr 1,266,688,890 kr 1,266,638,890
2026-10-26 annual 2030-12-31 kr 30.54 kr 30.93 ▲ 0.39 kr 7,520,277,778 kr 7,652,166,667
2026-10-26 annual 2029-12-31 kr 28.57 kr 28.69 ▲ 0.12 kr 7,146,058,160 kr 7,207,817,533
2026-10-26 annual 2028-12-31 kr 26.81 kr 26.96 ▲ 0.15 kr 6,628,000,408 kr 6,647,451,302
2026-10-26 quarter 2026-09-30 kr 3.53 kr 3.53 — kr 1,200,951,697 kr 1,200,973,126
2026-10-26 annual 2026-12-31 kr 11.83 kr 11.81 ▼ 0.02 kr 4,479,691,927 kr 4,478,204,354
2026-10-21 annual 2030-12-31 kr 30.58 kr 30.54 ▼ 0.04 kr 7,506,388,889 kr 7,520,277,778
2026-10-21 annual 2026-12-31 kr 11.79 kr 11.83 ▲ 0.04 kr 4,477,495,397 kr 4,479,691,927
2026-10-21 quarter 2026-09-30 kr 3.56 kr 3.53 ▼ 0.03 kr 1,200,102,169 kr 1,200,951,697
2026-10-21 annual 2027-12-31 kr 17.32 kr 17.30 ▼ 0.02 kr 5,322,174,426 kr 5,345,530,402
2026-10-21 quarter 2027-12-30 kr 5.75 kr 5.67 ▼ 0.08 kr 1,451,275,933 kr 1,486,433,333
2026-10-21 annual 2029-12-31 kr 28.67 kr 28.57 ▼ 0.10 kr 7,130,967,251 kr 7,146,058,160
2026-10-21 annual 2028-12-31 kr 27.56 kr 26.81 ▼ 0.75 kr 6,622,492,480 kr 6,628,000,408
2026-10-21 quarter 2027-06-30 kr 4.71 kr 4.79 ▲ 0.08 kr 1,312,821,667 kr 1,349,266,667
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms